Laminin-332 and Oesophageal Cancer
Author Information
Author(s): Baba Y, Iyama K-i, Hirashima K, Nagai Y, Yoshida N, Hayashi N, Miyanari N, Baba H
Primary Institution: Kumamoto University
Hypothesis
Does laminin-332 promote the invasion of oesophageal squamous cell carcinoma via PI3K activation?
Conclusion
Laminin-332 expression is associated with poor prognosis in oesophageal squamous cell carcinoma and promotes invasiveness through PI3K activation.
Supporting Evidence
- Laminin-332 was expressed in 44% of ESCC cases.
- Patients with laminin-332-positive tumours had significantly shorter disease-free survival.
- Laminin-332 expression was significantly correlated with TNM stage.
- Blocking the PI3K pathway reduced the invasiveness of ESCC cells.
- Purified laminin-332 increased the invasiveness of ESCC cells.
Takeaway
Laminin-332 is a protein that helps cancer cells spread in oesophageal cancer, and blocking it might help treat the disease.
Methodology
The study involved immunohistochemical examination of laminin-332 in resected ESCC specimens and in vitro experiments using ESCC cell lines.
Potential Biases
Potential bias in the assessment of immunohistochemical staining due to subjective interpretation.
Limitations
The study only included patients who underwent curative surgical resection, which may limit the generalizability of the findings.
Participant Demographics
126 consecutive patients with oesophageal squamous cell carcinoma, mean age 63.7 years, 106 males and 20 females.
Statistical Information
P-Value
0.036
Confidence Interval
95% CI for disease-free survival: 1.18–2.64
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website